Aisling Capital - Company Review
Aisling Capital - Company ReviewSummary
Aisling Capital (Aisling) is an investment firm. It focuses on investing in companies which develop and commercialize healthcare products, services and technologies. The firm also provides investments for drug development, manufacturing and provider service companies across the healthcare industry. It invests in both private and public companies utilizing a wide variety of investment structures. The company offers investment services to healthcare sectors such as biopharmaceutical, consumer, diagnostics, service and medical device. Aisling companies portfolio includes Aclaris Therapeutics Inc, Adma Biologics Inc, Agile Therapeutics Inc, Adams Respiratory Therapeutics Inc, T2 Biosystems Inc, Ajax Health, Advion Inc and others. Aisling is headquartered in Newyork, the US.
This comprehensive company report of Aisling Capital provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.